The U.S. Food and Drug Administration (FDA) has accepted Replimune's BLA resubmission for RP1 in combination with nivolumab, which targets advanced melanoma in patients who have not responded to prior ...
The Company intends to monitor the closing bid price of its ADS on the Nasdaq and may, if appropriate, consider implementing ...
The addition of an investigational therapeutic cancer vaccine to first-line pembrolizumab exhibited activity among patients ...
Takeda Pharmaceutical Company Limited ( NYSE: TAK) Discusses Global Strategic Collaboration for Next-Generation Oncology Assets and ADC Molecules October 22, 2025 9:00 AM EDT ...
Discusses 2-Year Phase II Data and AI Immunology Platform in High-Risk Melanoma October 22, 2025 10:30 AM EDTCompany ...
Detailed price information for Summit Therapeu ADR (SMMT-Q) from The Globe and Mail including charting and trades.
For instance, in metastatic melanoma—a disease previously considered inevitably fatal—the combination of nivolumab with or without ipilimumab ... 112 Given that the mechanism of action of ICI relies ...
Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been ...
A research team led by Prof. Ben Ko Chi-bun, Associate Professor of the PolyU Department of Applied Biology and Chemical Technology, has discovered the critical mechanism of action of tetrandrine, a ...
Twenty-five years ago, in an episode of Larry David’s “Curb Your Enthusiam” television series titled “Affirmative Action,” the comedian’s friend Richard Lewis introduces him to Dr. Grambs, a Black ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback